Oura, the company behind the popular smart ring, is reportedly planning a September IPO that could value the business at more than $16 billion. This **Oura IPO valuation** represents a significant jump from its $10.9 billion valuation just last year. The wearable technology company, which has offices in San Francisco and Finland, is looking to raise up to $3 billion in the U.S. public offering, with existing investors expected to sell a substantial portion of their shares.
A Major Leap in Valuation
The potential Oura IPO valuation of over $16 billion marks an enormous increase from the $10.9 billion valuation the company secured in September 2025, when it closed an $875 million Series E funding round. That round attracted major institutional backing from Fidelity, ICONIQ, Whale Rock, and Atreides, who joined earlier investors including Dexcom, The Chernin Group, Forerunner Ventures, Coatue, and Temasek. The company announced in May that it had filed confidentially for an IPO, and the upcoming September timeline suggests the process is moving forward as planned.
Revenue Growth and Financial Performance
Oura has demonstrated remarkable revenue growth, with the company reporting $500 million in revenue for 2024. This figure jumped to approximately $1 billion in 2025, and the company has projected it expects to generate close to $2 billion in revenue during 2026. Much more detail will become available once the company’s S-1 filing becomes publicly accessible, providing investors with a comprehensive look at its financial health and business operations. The company currently employs more than 900 people across its operations.
Crowded Wearables Market
The wearables space has become increasingly crowded over the past few years. Samsung launched its own smart ring, the Galaxy Ring, two years ago, entering a market that Oura helped pioneer. However, Oura’s most direct competitor may be fitness band maker Whoop, which has undergone its own significant transformation.
Whoop’s Evolution
Whoop, once positioned primarily as a performance tool for elite athletes and young men, has spent the past year courting a much broader audience. The company has expanded its offerings to include hormone tracking and blood-panel testing for perimenopause and thyroid health, making the platform more accessible to diverse user demographics. This strategic pivot drove Whoop’s own valuation up to $10 billion in March.
Oura’s Strategic Shift
Oura has followed a similar path, evolving from its initial niche of biohacking CEOs into a more mainstream sleep-and-recovery brand. This repositioning has helped the company appeal to a wider consumer base interested in health monitoring, sleep quality, and overall wellness tracking. The company’s ability to broaden its appeal while maintaining its premium positioning has been key to its growth story.
Legal Challenges
Not all of Oura’s recent attention has been positive. A proposed class action lawsuit filed last week in San Francisco is accusing Oura of misleading consumers about the accuracy of its sleep tracking features. The filing alleges that Oura claims not just to measure heartbeat or temperature but the exact stage of sleep the wearer is experiencing. The lawsuit contends that accurately determining sleep stages requires electrodes on the scalp and sensors on the eyes, which only a hospital or clinical setting can provide.
Oura’s Defense
In response, an Oura spokesperson pushed back against the claims, stating the company plans to defend against them in the appropriate legal forum. The company emphasized that while the Oura Ring is not a medical device or a substitute for a clinical sleep study, its sleep staging has been validated and compared favorably in multiple studies against polysomnography, which is considered the gold standard for sleep measurement. Multiple third-party, independent studies support Oura’s claims of accuracy, and the company has transparently reported on the mechanisms and measures that inform its sleep staging.
What This Means for Investors
The potential September IPO presents both opportunities and challenges for prospective investors. The significant Oura IPO valuation jump from $10.9 billion to over $16 billion demonstrates strong market confidence in Oura’s growth trajectory. The company’s revenue figures show impressive momentum, with projections suggesting continued expansion through 2026. However, investors will want to carefully examine the competitive landscape and legal challenges when the S-1 filing becomes available.
Industry Implications
Oura’s potential public debut at such a substantial Oura IPO valuation could have ripple effects across the wearables industry. A successful offering might encourage other wearable technology companies to pursue public listings and could validate the premium valuation multiples attached to health-focused wearable devices. The company’s ability to command a $16 billion-plus valuation while facing legal challenges and increasing competition will be watched closely by industry observers.
As the September timeline approaches, more information about the IPO structure, pricing, and investor interest will emerge. For now, the Oura IPO valuation of over $16 billion positions the smart ring maker as one of the most significant wearable technology IPOs in recent memory.
